D. Gallardo

Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico

C. Pérez-Plasencia, C. Villarreal-Garza, A. Mohar, 2015, Cancer.

Cisplatin, radiation, and amifostine in carcinoma of the uterine cervix.

A. Mohar, G. Calderillo, J. G. De la Garza, 1999, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

A phase II study of gemcitabine plus cisplatin in previously untreated advanced ovarian cancer.

G. Calderillo, J. G. De la Garza, A. Serrano, 2006, Anticancer research.

First-Line Therapy in Ovarian Cancer Trials

H. Kitchener, J. McAlpine, L. Rubinstein, 2011, International Journal of Gynecologic Cancer.

Phase II Study of Neo‐adjuvant Gemcitabine Plus Epirubicin in Primarily Unresectable Locally Advanced Breast Cancer

G. Calderillo, J. G. De la Garza, D. Gallardo, 2008, The breast journal.

Adjuvant Chemotherapy with Doxorubicin and Dacarbazine has No Effect in Recurrence‐Free Survival of Malignant Phyllodes Tumors of the Breast

G. Hortobagyi, A. González-Angulo, K. Broglio, 2007, The breast journal.

ICON8: A GCIG phase III randomised trial evaluating weekly dosedense chemotherapy integration in first- line epithelial ovarian/fallopian tube/primary peritoneal carcinoma (EOC) treatment: Results of primary progression- free survival (PFS) analysis

J. Brenton, J. Ledermann, I. McNeish, 2017 .

The MAD1 1673 G→A polymorphism alters the function of the mitotic spindle assembly checkpoint and is associated with a worse response to induction chemotherapy and sensitivity to treatment in patients with advanced epithelial ovarian cancer

A. Mohar, D. Prada, J. Mendoza, 2013, Pharmacogenetics and genomics.

Phase II study of gemcitabine plus cisplatin in metastatic breast cancer

L. Oñate-Ocaña, G. Calderillo, D. Gallardo, 2006, Anti-cancer drugs.

Cancer‐associated prothrombotic pathways: leucocytosis, but not thrombocytosis, correlates with venous thromboembolism in women with ovarian cancer

O. Arrieta, Evelyn Cortés, D. Gallardo, 2020, Internal medicine journal.

Neoadjuvant chemotherpay with gemcitabine plus carboplatin in advanced and unresectable gastric cancer

J. Mora, D. Gallardo, C. Leoner, 2005 .